Acadia Healthcare Company, Inc. $ACHC Shares Sold by Congress Asset Management Co.

Congress Asset Management Co. lowered its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 21.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 133,860 shares of the company’s stock after selling 36,177 shares during the period. Congress Asset Management Co. owned 0.14% of Acadia Healthcare worth $3,314,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Wedmont Private Capital purchased a new stake in shares of Acadia Healthcare in the third quarter valued at about $279,000. Corient Private Wealth LLC lifted its position in Acadia Healthcare by 55.6% during the 2nd quarter. Corient Private Wealth LLC now owns 19,056 shares of the company’s stock worth $432,000 after acquiring an additional 6,813 shares during the period. Orion Porfolio Solutions LLC grew its stake in shares of Acadia Healthcare by 68.8% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 31,479 shares of the company’s stock valued at $714,000 after purchasing an additional 12,831 shares during the last quarter. State of Wyoming increased its holdings in shares of Acadia Healthcare by 1,631.1% in the second quarter. State of Wyoming now owns 24,356 shares of the company’s stock valued at $553,000 after purchasing an additional 22,949 shares during the period. Finally, Caxton Associates LLP lifted its holdings in shares of Acadia Healthcare by 1,234.5% during the second quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock worth $3,936,000 after purchasing an additional 160,482 shares during the period.

Analyst Ratings Changes

ACHC has been the subject of a number of analyst reports. Cantor Fitzgerald set a $17.00 price objective on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Bank of America lowered Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $21.50 to $13.00 in a report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft cut their target price on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Leerink Partners restated a “market perform” rating and issued a $14.00 price target (down from $25.00) on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Finally, Leerink Partnrs cut Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 3rd. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of “Hold” and an average price target of $22.75.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $14.46 on Tuesday. The business has a 50 day moving average price of $18.20 and a 200 day moving average price of $21.03. The company has a market capitalization of $1.33 billion, a P/E ratio of 12.36, a PEG ratio of 3.55 and a beta of 0.91. Acadia Healthcare Company, Inc. has a 1-year low of $12.63 and a 1-year high of $47.08. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. During the same period in the previous year, the business earned $0.91 earnings per share. Acadia Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.